Open AccessAntiarrhythmogenic effect of omega‐3 fatty acid ethyl esters in a patient treated with Omacor after a non‐Q‐wave myocardial infarction
Author(s) -
Ardashev Andrey,
Zhelyakov Evgeny,
Kuzovlev Oleg
Publication year - 2014
Publication title -
journal of arrhythmia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 21
eISSN - 1883-2148
pISSN - 1880-4276
DOI - 10.1016/j.joa.2013.04.008
Subject(s) - medicine , palpitations , myocardial infarction , cardiology , sick sinus syndrome , ethyl ester , omega 3 fatty acid , ventricular tachycardia , fatty acid , tachycardia , polyunsaturated fatty acid , chemistry , docosahexaenoic acid , organic chemistry
An 84‐year‐old man reported several episodes of palpitations over the previous 6 months. He had a history of a prior non‐Q‐wave myocardial infarction (MI) and had received a dual‐chamber pacemaker for control of subsequent sick sinus syndrome. Pacemaker data revealed 8000 premature ventricular beats (PVBs) daily and nonsustained ventricular tachycardia (NSVT). The patient agreed to add omega‐3 fatty acid ethyl ester supplementation (1 g/day) to his treatment regimen. Pacemaker analyses 3 months later demonstrated no NSVT and only 215 PVBs daily. In more than 1 year of follow‐up, the patient has remained well and has had no further ventricular arrhythmias. We conclude that omega‐3 fatty acid ethyl ester supplementation may be beneficial in post‐MI patients with pacemakers who develop ventricular arrhythmias.